Tuberculosis in the Shadow of War: A Comparison of Turkish and Syrian Patients in Türkiye's Border Province
Öz
Background: Today, there are approximately 250 million international and 763 million internal migrants in the world. External migration to Türkiye is mostly from Syria, Afghanistan, and Iraq. War, which is the worst of the adverse conditions, and the resulting migrations increase susceptibility to tuberculosis disease. This study aimed to evaluate tuberculosis, which is facilitated by unfavorable socioeconomic conditions, in a Turkish border province neighboring Syria, according to ethnicity.
Materials and Methods: The data used in the study belong to the year 2022 and were taken from the files archived in Şanlıurfa Tuberculosis Dispensary Institution. Demographic information, diagnosis and treatment information of Turkish and Syrian patients were obtained from the files and evaluated.
Results: In this study, we found that approximately one fifth of the patients were Syrian. It was found that the average age of Syrian patients was lower and the rate of patients in the 0-14 age range was higher than that of Turkish patients. The rate of pulmonary tuberculosis was higher in Syrian patients than extrapulmonary tuberculosis. While streptomycin resistance was most common in Turkish patients, rifampicin resistance was most common in Syrian patients.
Conclusions: Our study reminded us that countries receiving immigration are at risk of infectious diseases. As a result of our study, some differences were found between Turkish and Syrian patients in terms of sociodemographic and disease-related characteristics. Our study has once again revealed that drug resistance differences based on ethnicity differences should be investigated.
Anahtar Kelimeler
Destekleyen Kurum
Etik Beyan
Teşekkür
Kaynakça
- 1. T.C. Ministry of Health. Tuberculosis Diagnosis Treatment Guide, Ministry of Health Publications Ankara, 2011.
- 2. World Health Organization (March 2007: Retrieved on 10 January 2008). Tuberculosis Fact sheet N°104 - Global and regional incidence.
- 3. D’Ambrosio L, Centis R, Tiberi S, Tadolini M, Dalcolmo M, Rendon A, et al. Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review. J Th orac Dis. 2017;9(7):2093-101.
- 4. Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019;20:393(10181):1642-56.
- 5. Githinji LN, Gray DM, Zar HJ. Lung function in HIV-infected children and adolescents. Pneumonia (Nathan). 2018;25:10:6.
- 6. Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;2:378(9785):57-72.
- 7. Kolcu G, Demirbaş T, Yıldırım AE, Gökgöz M, Öngel K. The Importance of Anamnesis Findings in Measles Disease. Smyrna Medical Journal. 2015;5(3):7-10.
- 8. Topçu S, Beşer A. Migration and Health. CU School of Nursing Journal. 2006;10(3): 37-42.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Göğüs Hastalıkları
Bölüm
Araştırma Makalesi
Yazarlar
Erken Görünüm Tarihi
27 Mart 2026
Yayımlanma Tarihi
27 Mart 2026
Gönderilme Tarihi
4 Şubat 2026
Kabul Tarihi
17 Mart 2026
Yayımlandığı Sayı
Yıl 2026 Cilt: 23 Sayı: 1